PubRank

Tetsuo Kase

Author PubWeight™ 25.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A phylogenetic study of human respiratory syncytial viruses group A and B strains isolated in two cities in Japan from 1980-2002. J Med Virol 2005 1.09
2 Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury. J Virol 2010 0.99
3 Type I interferon limits influenza virus-induced acute lung injury by regulation of excessive inflammation in mice. Antiviral Res 2013 0.98
4 Norovirus storm in Osaka, Japan, last winter (2006/2007). Jpn J Infect Dis 2007 0.97
5 Development of an immunochromatographic assay specifically detecting pandemic H1N1 (2009) influenza virus. J Clin Microbiol 2010 0.96
6 Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. Int Immunopharmacol 2009 0.94
7 A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan. Vaccine 2006 0.92
8 Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine. Vaccine 2006 0.85
9 Isolation and characterization of a novel recombinant human adenovirus species D. J Med Microbiol 2012 0.84
10 Efficacy of inactivated trivalent influenza vaccine in alleviating the febrile illness of culture-confirmed influenza in children in the 2000-2001 influenza season. Vaccine 2006 0.84
11 Molecular epidemiology of human adenoviruses d associated with epidemic keratoconjunctivitis in Osaka, Japan, 2001-2010. Jpn J Infect Dis 2013 0.83
12 Combined administration of (L)-cystine and (L)-theanine enhances immune functions and protects against influenza virus infection in aged mice. J Vet Med Sci 2009 0.83
13 Molecular cloning of mouse collectin liver 1. Biosci Biotechnol Biochem 2002 0.83
14 A case of chikungunya fever imported from India to Japan, follow-up of specific IgM and IgG antibodies over a 6-month period. Jpn J Infect Dis 2010 0.82
15 Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models. Vaccine 2007 0.82
16 Anti-influenza A virus activities of mannan-binding lectins and bovine conglutinin. J Vet Med Sci 2007 0.81
17 A case of urethritis caused by human adenovirus type 56. Jpn J Infect Dis 2012 0.81
18 Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan. Vaccine 2010 0.80
19 The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice. Vaccine 2005 0.79
20 Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents. Vaccine 2008 0.79
21 Retrospective assessment of influenza vaccine effectiveness among the non-institutionalized elderly population in Japan. Vaccine 2005 0.79
22 Alice in Wonderland syndrome caused by the 2009 pandemic H1N1 influenza A virus. Pediatr Infect Dis J 2011 0.78
23 Early therapy with neuraminidase inhibitors for influenza A (H1N1) pdm 2009 infection. Pediatr Int 2013 0.77
24 Serum immunoglobulin G subclass levels and estimated clinical severity caused by possible influenza A (H1N1) pdm 2009 infection. J Infect Chemother 2013 0.77
25 The impact of antigenic drift of influenza A virus on human herd immunity: Sero-epidemiological study of H1N1 in healthy Thai population in 2009. Vaccine 2010 0.77
26 IgG3 deficiency and severity of 2009 pandemic H1N1 influenza. Pediatr Int 2012 0.77
27 Genetic analysis of human adenovirus type 54 detected in Osaka, Japan. Jpn J Infect Dis 2011 0.76
28 Type I interferon plays opposing roles in cytotoxicity and interferon-γ production by natural killer and CD8 T cells after influenza A virus infection in mice. J Innate Immun 2014 0.76
29 Detection of influenza vaccine effectiveness among nursery school children: Lesson from a season with cocirculating respiratory syncytial virus. Hum Vaccin Immunother 2015 0.75
30 Immunogenicity and Efficacy of A/H1N1pdm Vaccine Among Subjects With Severe Motor and Intellectual Disability in the 2010/11 Influenza Season. J Epidemiol 2016 0.75
31 Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons. Hum Vaccin Immunother 2015 0.75
32 Longitudinal study on respiratory viral co-infections in the presence or absence of clinical manifestation in infants aged 0-2 years. Jpn J Infect Dis 2014 0.75
33 Application of a modified loop-mediated isothermal amplification kit for detecting Norovirus genogroups I and II. J Med Virol 2009 0.75
34 [Characterization of a nonspecific inhibitor found in human sera raised against the 2006/07 influenza vaccine strain A/Hiroshima/52/2005 (H3N2) virus]. Kansenshogaku Zasshi 2012 0.75
35 Prevalence of enterovirus in Osaka, Japan, between April and September 2008. Jpn J Infect Dis 2009 0.75
36 [Comparison of detection sensitivity in rapid-diagnosis influenza virus kits]. Kansenshogaku Zasshi 2009 0.75
37 An outbreak of measles classified as genotype H1 in 2008 in Osaka Prefecture. Jpn J Infect Dis 2009 0.75
38 Humoral immune response to influenza A(H1N1)pdm2009 in patients with natural infection and in vaccine recipients in the 2009 pandemic. Viral Immunol 2014 0.75
39 Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models. Adv Exp Med Biol 2006 0.75